Healthcare Triangle, Inc. — Form 8-K Summary
Business Context and Reporting Period
Healthcare Triangle, Inc. filed a Form 8-K regarding a Nasdaq continued-listing deficiency. The report date was March 20, 2024, and the deficiency was based on stockholders’ equity reported in the Company’s Form 10-K for the year ended December 31, 2023.
Key Financial Metrics and Liquidity
- Stockholders’ equity at December 31, 2023: $538,000.
- Nasdaq minimum stockholders’ equity requirement: $2.5 million.
- The filing does not provide clear values for revenue, net income, cash flow, margins, debt, cash, or other liquidity measures.
Material Change and Listing Deficiency
On March 20, 2024, Nasdaq notified the Company that it was not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires at least $2.5 million of stockholders’ equity for continued listing. The reported $538,000 of equity was below the requirement.
The Nasdaq notice had no immediate effect on the listing or trading of the Company’s common stock. The Company remains listed on Nasdaq, subject to compliance with other continued-listing requirements.
Outlook, Contingencies, and Management Commentary
- The Company had until May 6, 2024 to submit a plan to regain compliance.
- If Nasdaq accepted the plan, the Company could receive up to 180 calendar days from March 20, 2024, or until September 16, 2024, to demonstrate compliance.
- If the plan was rejected or the Company failed to regain compliance during an approved extension, it could request a hearing before an independent panel. A timely hearing request would stay suspension or delisting action pending the hearing process and any additional extension granted.
- Management stated that it intended to submit a compliance plan and evaluate available options to restore compliance, but disclosed that there could be no assurance the plan would be accepted or that compliance would be regained.
- The Company stated that the notice did not affect its business, operations, or SEC reporting obligations.
Important Facts for Investors to Verify
- Whether the Company submitted its compliance plan by May 6, 2024.
- Whether Nasdaq accepted the plan and granted an extension through September 16, 2024.
- Whether the Company restored stockholders’ equity to at least $2.5 million or otherwise satisfied Nasdaq’s requirements.
- Any subsequent Nasdaq determination, hearing request, suspension, delisting action, capital raise, restructuring, or other measure affecting stockholders’ equity.
- The Company’s current cash, debt, operating losses, and liquidity position, which are not provided in this filing.